Solid Tumors With FGFR2 Alterations, Adult
3 clinical trials · Condition
◉ Watch Solid Tumors With FGFR2 Alterations, Adult
| Record | Firm | Date |
|---|---|---|
| A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations (NCT06287918) | 3H (Suzhou) Pharmaceuticals Co., Ltd. | 2026-06-01 |
| A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations (NCT06800196) | KinoTeck Therapeutics Co., Ltd | 2025-04-10 |
| A Study of 3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations (NCT06378593) | 3H (Suzhou) Pharmaceuticals Co., Ltd. | 2024-06-17 |
Track Solid Tumors With FGFR2 Alterations, Adult automatically
Every clearance here is in the API, with alerts when new ones post.